Enantioselective Total Synthesis of Bistramide A by Crimmins, Michael T. & DeBaillie, Amy C.
Enantioselective Total Synthesis of Bistramide A
Michael T. Crimmins* and Amy C. DeBaillie
Department of Chemistry, Venable and Kenan Laboratories of Chemistry, University of North
Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290
Abstract
The enantioselective synthesis of bistramide A has been achieved with a longest linear sequence of
eighteen steps. The synthetic strategy involves the use of a distereoselective glycolate alkylation, an
aldol addition of a chlorotitanium enolate of N-acylthiazolidinthione, and a Sharpless asymmetric
epoxidation to synthesize the three key fragments.
Bistramide A1 (1) is a member of a new class of bioactive molecules isolated from the marine
ascidian Lissoclinum bistratum. The bistramides demonstrate significant neuro- and cytotoxic
properties as well as profound effects on cell cycle regulation.2 In particular, bistramide A has
an IC50 of 0.03–0.32 μg/mL for P388/dox, B16, HT29, and NSCLC-N6 cell lines.3 Studies
have shown that bistramide A is cell permeable, blocks sodium channels,4 and induces highly
selective activation of a single protein kinase C (PKC) isotype δ.5 The biological activity of
bistramide A, as well as the other bistramides, has rendered them potential candidates for the
treatment of slowly evolving tumors, such as non-small cell pulmonary carcinoma.2
From the time of their original isolation,1a the bistramides have presented a challenging
stereochemical conundrum. Synthetic efforts toward the bistramides6 were hampered by the
lack of information regarding their relative and absolute configuration prior to Wipf’s
theoretical and synthetic studies.6d,6g Kozmin and coworkers7 have recently reported the first
total synthesis of bistramide A, thus confirming Wipf’s prediction of the stereochemical
assignment of bistramide C.6d,6g
Herein we disclose a convergent, enantioselective, total synthesis of bistramide A. At the onset
of this project, the absolute configuration of bistramide A had not been established. Therefore,
our goal was to devise a strategy, which would allow either enantiomer of the three key subunits
to be prepared, with the added requirement that either configuration at C39 could be accessed.
Hence, it was envisioned that bistramide A would derive from three fragments: pyran 2,
carboxylic acid 3, and spiroketal fragment 4 (Figure 1). The pyran fragment 2 was constructed
as shown in Scheme 1. Exposure of aldehyde 58 to the chlorotitanium enolate of N-propionyl
thiazolidinethione 69 proceeded smoothly (87%) with excellent diastereoselectivity (>98:2 dr).
The chiral auxiliary was reductively cleaved, and the resulting aldehyde was exposed to Ph3P
= CHCO2Et to give α,β-unsaturated ethyl ester 8 in 78% yield over two steps. Hydrogenation
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in the presence of PPTS. Reductive acylation10 of the lactone delivered acetate 9 as an
inconsequential 7:1 mixture of anomers. Treatment of acetate 9 with the 2-
trimethylsilyloxy-1,3-pentadiene,11 in the presence of TMSOTf, installed the α,β-unsaturated
ketone moiety of pyran 10 in 87% yield (9:1 dr). The TIPS ether was removed, and the resulting
primary alcohol was oxidized to the acid.6f Esterification of the acid with hydoxysuccinimide
gave pyran 2.
The synthesis of carboxylic acid 3 began by transformation of allylic alcohol 1112 to the epoxy
alcohol in 95% yield (98% ee) via a Sharpless asymmetric epoxidation13 (Scheme 2).
Treatment of the epoxy alcohol with lithium dimethylcuprate yielded the 1,3-diol accompanied
by the undesired 1,2-diol (6:1). The minor isomer was readily removed by treating the mixture
with sodium periodate to yield 1,3-diol 12 in 71% yield. Protection of diol 12 as the bis-silyl
ether followed by oxidative cleavage of the PMB ether provided alcohol 13 in 95% yield over
two steps. The azide moiety was then installed via a Mitsunobu reaction14 with
diphenylphosphoryl azide, whereupon the primary TBS ether was selectively cleaved with
CSA in methanol to yield alcohol 14. Oxidation15 of the primary alcohol to the carboxylic
acid, followed by deprotection of the TBS ether gave the hydroxy acid in 66% yield over two
steps. The azide moiety was readily reduced to the primary amine with hydrogen and Pd/C
followed by in-situ acylation to yield the desired carboxylic acid fragment 3.
Construction of the spiroketal fragment 4 began with an asymmetric glycolate alkylation16 of
the sodium enolate of imide 15 with allyl iodide to produce the allylated acyl oxazolidinone
in 81% yield (>98:2 dr; Scheme 3). Reductive cleavage of the auxiliary, followed by oxidation
of the resulting primary alcohol under Swern17 conditions gave aldehyde 16. Subjection of
aldehyde 16 to a modified Julia reaction18 with sulfone 17 gave diene 18 as a 60:40 mixture
of E:Z isomers. A cross-metathesis reaction of diene 18 with methyl acrylate provided the
unsaturated methyl ester in 87% yield. Hydrogenation of the two alkenes resulted in
concomitant cleavage of the benzyl ether, whereupon treatment with acid gave lactone 19 (70%
yield, 2 steps). Addition of lactone 19 to the lithium acetylide of alkyne 20 produced a keto-
alcohol, which was immediately exposed to hydrogen and Pd/C at 50 psi. As anticipated, the
resulting trihydroxy ketone spontaneously cyclized to exclusively produce spiroketal 21 in
83% yield over two steps. Installation of the phthalimide under Mitsunobu14 conditions,
followed by deprotection of the TBDPS ether gave alcohol 22 in 84% yield over two steps.
Treatment of alcohol 22 with the Dess-Martin reagent19 provided the aldehyde, which was
subjected to a Horner-Wadsworth-Emmons olefination20 with phosphonate 23 to install the
E-olefin (C36–C37). The completed spiroketal fragment 4 was then obtained by stereoselective
reduction of the resulting ketone with Corey’s oxazoborolidine21 to establish the C39
stereogenic center.
With the three required fragments in hand, their assembly to bistramide A was undertaken.
Cleavage of the phthalimide protecting group of 4 with methanol and methylamine gave the
amine, which was immediately exposed to a PyBOP-mediated condensation with acid 3
delivering amide 24 in 88% yield over two steps. Removal of the Fmoc group with subsequent
exposure of the unpurified amine to ester 2 provided synthetic bistramide A which was identical
in all respects (1H, 13C, [α]D, MS) to the natural product. The synthesis was completed with a
longest linear sequence of eighteen steps.
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Retrosynthesis of bistramide A.
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Synthesis of Pyran 2
a Conditions: (a) TiCl4, NMP, (−)-sparteine, CH2Cl2, −78 °C, 6, 87%; (b) i-Bu2AlH, THF,
−78 °C; (c) Ph3P = CHCO2Et, CH2Cl2, 78% (2 steps); (d) H2, Raney Ni, EtOH (e) PPTS,
CH2Cl2, 40 °C, 81% (two steps); (f) i-Bu2AlH, pyridine, DMAP, Ac2O, CH2Cl2, −78 °C to
−20 °C, 96%; (g) Et3N, TMSOTf, 3-penten-2-one, CH2Cl2, 0 °C then −78 °C, then add acetate
9, 87%, 9:1 dr; (h) H2SiF6, CH3CN, 0 °C, 75%; (i) H5IO6/CrO3, CH3CN, 77%; (j) N-
hydroxysuccinimide, EDC·HCl, CH2Cl2, 100%.
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Preparation of Carboxylic Acid Fragment 3
a Conditions: (a) L-(+)-DET, Ti(Oi-Pr)4, t-BuOOH, CH2Cl2, 4 Å sieves, −20 °C, 95%, 98%
ee; (b) Me2CuLi, Et2O, −50 °C to 25 °C, 6:1 of 1,3- to 1,2-diol; NaIO4, H2O, 71%; (c) TBSOTf,
2,6-lutidine, CH2Cl2, 0 °C, 97%; (d) DDQ, pH 7 buffer, CH2Cl2, 0 °C, 98%; (e) DEAD,
PPh3, (PhO)2PON3, THF, 0 °C, 90%; (f) CSA, MeOH, CH2Cl2, 0 °C, 85%; (g) NaClO2,
TEMPO, CH3CN, 35 °C, 95%; (h) HF/pyr., THF, 70%; (i) H2, Pd/C, Fmoc-OSu, THF, 70%.
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Preparation of Spiroketal Fragment 4
a Conditions: (a) NaHMDS, allyl iodide, THF, PhMe, −78 °C to −45 °C, 81%; (b) LiBH4,
MeOH, Et2O, 98%; (c) Et3N, DMSO, (COCl)2, CH2Cl2, −78 °C to 25 °C, 98%; (d) LiHMDS,
THF, sulfone 17, then aldehyde 16, −78 °C to −20 °C, 87%; (e) Cl2(Cy3P)(IMes)Ru = CHPh,
methyl acrylate, CH2Cl2, 40 °C, 87%; (f) H2, Pd/C, EtOAc; (g) p-TSA, benzene, 80 °C, 70%
(two steps); (h) alkyne 20, n-BuLi, −78 °C, then lactone 19; (i) H2, Pd/C, MeOH, EtOAc, 83%
(2 steps); (j) PPh3, DEAD, phthalimide, THF, 0 °C; (k) HF/pyr., THF, 84% (2 steps); (l) Dess-
Martin periodinane, CH2Cl2, pyr., 92%; (m) Ba(OH)2, THF, MeCOCH(Me)P(O)(OEt)2 (23),
58%; (n) (R)-CBS, catecholborane, toluene, −78 °C, 65%, >98:2 dr.
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Synthesis of Bistramide A
a Conditions: (a) MeOH, MeNH2, 65 °C; (b) PyBOP, 3, DIEA, DMF 88% (2 steps); (c)
Et2NH, DMF; (d) 2, DMF 82% (2 steps).
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